Parameters of Stromal Activation and Epithelial to Mesenchymal Transition as Predictive Biomarkers for Induction Chemotherapy in Patients With Locally Advanced Oral Cavity and Oropharyngeal Squamous Cell Cancer-Reference-Cited by-同舟云学术

Parameters of Stromal Activation and Epithelial to Mesenchymal Transition as Predictive Biomarkers for Induction Chemotherapy in Patients With Locally Advanced Oral Cavity and Oropharyngeal Squamous Cell Cancer

Published:2016-12-01 Issue:4 Volume:9 Page:374-381
ISSN:1976-8710
Container-title:Clinical and Experimental Otorhinolaryngology
language:en
Short-container-title:Clin Exp Otorhinolaryngol

Author:

Geweiler Jana,Inhestern Johanna,Berndt Alexander,Guntinas-Lichius Orlando

Publisher

Korean Society of Otorhinolaryngology-Head and Neck Surgery

Subject

Otorhinolaryngology,Surgery

Link

http://www.e-ceo.org/upload/pdf/ceo-2015-01683.pdf

Reference33 articles.

1. Current status and future directions in induction chemotherapy for head and neck cancer

2. Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

3. Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

4. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

5. Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma: A Single Center Study;2022-11-07

3. Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma;Head & Neck;2019-01-23

4. Number of positive lymph nodes better predicts survival for oral cavity cancer;Journal of Surgical Oncology;2019-01-23

5. Overexpression of cysteine-glutamate transporter and CD44 for prediction of recurrence and survival in patients with oral cavity squamous cell carcinoma;Head & Neck;2018-10-10